Portfolio Lab

LifeStance Health Group, Inc.

  • Stock
  • Ticker LFST
  • Nasdaq

Health care · Health care services · USA

$13.82 +3.60%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of LifeStance Health Group, Inc. since 06/2021, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

LFSTGlobal equities (VT)

$10,000 grew to $11,536. Global equities (VT): $14,653.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −86.9% in 08/2025, measured from the peak in 07/2021. The old peak has not been reached again yet.

1-year return
+123.6%
5-year return p.a.
+9.8%
Return p.a. since 06/2021
−8.1%
Volatility p.a.
62.9%
Largest decline
−86.9%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue325333345364382403435456
Operating income1.11.6-3.07.418223133
EBITDA11127.71828334245
Net income-7.10.7-3.81.112142422
Balance sheet
Total assets2,1182,1052,1472,1492,2042,1462,1812,186
Liabilities672648673656683668704694
Equity1,4461,4571,4741,4931,5211,4771,4771,492
Cash155134189204249195226219
Long-term debt280276273269266262259256
Cash flow
Operating cash flow62-3.16427583310037
Capital expenditure-6.3-7.2-7.8-10-11-11-12-15
Free cash flow56-10571747228822

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2023 at +58.5%, weakest 2022 at −48.1%. 1 of 4 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026–
6 Aug 2026–
7 May 2026–
25 Feb 2026–
6 Nov 2025–
7 Aug 2025–
7 May 2025–
27 Feb 2025–
7 Nov 2024–
8 Aug 2024–
9 May 2024–
28 Feb 2024–

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€4.8bn
Market cap in trading currency
$5.25bn
Enterprise value
$5.31bn
P/E
–
P/S
3.13
P/B
3.52
EV/Sales
3.16
EV/EBITDA
35.8
Earnings yield
–
FCF yield
3.4%

Results (last four quarters)

Revenue
$1.68bn
Gross profit
–
EBITDA
$148m
Net income
$71.9m
Earnings per share
–
Revenue per share
$4.41
Revenue growth
+25.3%
Earnings growth
+1,978.5%

Profitability

Gross margin
–
Operating margin
6.2%
Net margin
4.3%
Return on equity
4.8%
Return on assets
3.3%

Balance sheet and cash flow

Cash
$219m
Cash per share
$0.58
Financial debt
$272m
Debt/equity %
18
Current ratio
1.44
Book value per share
$3.93
Operating cash flow
$228m
Free cash flow
$179m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
–
Ex-dividend date
–

Shares and trading

Shares outstanding
380m
Volume
5.62m
Avg. volume 3 months
5.10m
Relative volume
1.1

Price and technicals

Price
$13.82
1 day
+3.6%
52-week high
$14.60
52-week low
$6.18
Distance to 52-week high
−5.3%
Distance to 52-week low
+123.6%
Distance to 50-day line
+7.1%
Distance to 200-day line
+40.3%
RSI (14)
54
Volatility 1M
47.0%

Performance

1 week
−1.8%
1 month
+10.0%
3 months
+13.7%
6 months
+87.0%
YTD
+96.3%
1 year
+123.6%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has LFST performed since 06/2021?

$10,000 grew to $6,311 by 20 Nov 2026, which is −8.1% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is LFST?

Volatility was 62.9% per year, measured on monthly returns. The largest decline from a peak was −86.9%, with the low in 08/2025.

How does LFST compare with a broad equity ETF?

Over the same period Global equities (VT) returned +8.0% per year at 15.1% volatility, LFST returned −8.1% at 62.9%. The correlation of monthly returns was 0.28; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

LifeStance Health Group, Inc. (LFST): Return and risk